Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2022 Mar 24;69(6):e29613. doi: 10.1002/pbc.29613

Figure 1. C9710 Kaplan-Meier Event Free and Overall Survival.

Figure 1

A. Event free survival for obese (n=29) versus non-obese (n=55) patients < 18 years old enrolled on C9710 was not statistically significant (p=0.42). Obese patients had a 5 year EFS of 63% versus 51% for non-obese pediatric patients. B. Overall survival for obese versus non-obese patients < 18 years old was not statistically significant. The 5-year OS for obese patients was 93% and non-obese pediatric patients 78%